The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|22|2264-2277

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.22, 2011-07, pp. : 2264-2277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1421-1434

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes

By MacAulay Katrina   Woodgett James R  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1265-1274

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes

By Eldar-Finkelman Hagit   Kaidanovich Oksana  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 555-561

Informa Healthcare

Access to resources Recommend Favorite

Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-01 ,pp. : 1435-1441

Bentham Science Publishers

Access to resources Recommend Favorite